SCHEMBL12574657

SCHEMBL12574657

CC(C)OC(=O)Nc1nnc2c(N(C)Cc3ccccc3)nccn12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM5 P41594 1/20 0.39
▸ ZAP70 P43403 1/20 0.37
▸ KARS1 Q15046 1/20 0.37
▸ MAPK14 Q16539 1/20 0.36
▸ OPRD1 P41143 1/20 0.35
▸ OPRK1 P41145 1/20 0.35
▸ GABRA1 P14867 1/20 0.35
▸ GABRG2 P18507 1/20 0.35
▸ GABRB3 P28472 1/20 0.35
▸ GABRA5 P31644 1/20 0.35
▸ ACACB O00763 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ PTGER1 P34995 1/20 0.34
▸ TSHR P16473 2/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ RPS6KB1 P23443 1/20 0.34
▸ HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12638869 0.86 MAPK14 (0.42) ZAP70KARS1MAPK14GABRA1GABRG2
SCHEMBL12574800 0.86 GRM5 (0.40) GRM5ZAP70KARS1CYP1A2CYP2C9
SCHEMBL12574759 0.85 NPC1 (0.38) GRM5ZAP70KARS1CYP1A2CYP2C9
SCHEMBL12574619 0.84 GRM5 (0.35) GRM5ZAP70KARS1MAPK14CYP1A2
SCHEMBL12574774 0.83 ADORA3 (0.35) GRM5ACACBMAP3K5
SCHEMBL12574734 0.82 GRM5 (0.37) GRM5ZAP70KARS1CYP1A2CYP2C9
SCHEMBL12574631 0.80 SMN1; SMN2 (0.36) GRM5CYP1A2CYP2C9CYP2C19PTGER1
SCHEMBL12574622 0.80 CYP1A2 (0.37) GRM5CYP1A2KDM4EALDH1A1KMT2A
SCHEMBL12574655 0.80 ADORA3 (0.48) GRM5ZAP70KARS1MAPK14KDM4E
SCHEMBL12574696 0.80 GRM5 (0.35) GRM5ZAP70KARS1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8329705-B2 Substituted triazolo-pyrazine compounds ARQULE, INC. (US) 2012-12-11 — — US disclosed
US-20110160215-A1 Substituted Triazolo-Pyrazine Compounds ARQULE, INC. (US) 2011-06-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110160215-A1 Substituted Triazolo-Pyrazine Compounds MKI67, TP53, THPO GRM5 607/4885ZAP70 687/4885KARS1 1193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback